LV amyloid burden measured by [18F]Florbetapir PET/CT is a powerful predictor of cardiovascular events in AL amyloidosis, according to the 2012 Mayo stage, as the link between amyloid burden and cardiovascular events was mainly mediated by NT-proBNP, a component of Mayo stage [39]. Here, NPPB is linked to amyloidosis.